Skip to content

Effects on adiposity-related biomarkers and nutrient intake status on metabolic syndrome

Effects on adiposity-related biomarkers and nutrient intake status on metabolic syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000366
Enrollment
200
Registered
2012-02-20
Start date
2008-07-29
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient Group: 100 adults over 20, who are diagnosed with metabolic syndrome Control Group: 100 adults over 20, who has no evidence of insulin resistant or other metabolic syndrome

Exclusion criteria

Exclusion criteria: None of the participants had been diagnosed with cardiovascular disease, hypertension, diabetes, infectious diseases, diseases of the liver, thyroid or kidney, malignancy, acromegaly, Cushing syndrome, or any other serious medical problems. Volunteers who were taking systemic glucocorticoids, blood glucose lowering medications (eg, metformin, thiazolidinediones), anti-inflammatory medications, and immunosuppressant drugs were also excluded.

Design outcomes

Primary

MeasureTime frame
Adipokines(Leptin, Adiponectin, Resistin), inflammatory cytokine(CRP, IL-6, CAMs, TNF-a, MCP-1)

Secondary

MeasureTime frame
nutrient intake

Countries

Korea, Republic of

Contacts

Public ContactYun Jung Bae

Hanbuk University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026